Recent Finacing
Recent Raise
Azellon Cell Therapeutics develops an autologous stem-cell–seeded bandage to repair torn meniscal cartilage as a non-surgical alternative and is initiating MHRA‑approved Phase I/IIa human trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors